ASCP BOC Scientist in Blood Banking (BB) Examination Practice Test
Blood banking practice covers the laboratory methods used to support transfusion, including red-cell serology, component selection, donor collection, and recognition of transfusion complications. Questions in this bank sample compatibility testing, antibody investigation, blood-component properties, and decisions made when a donor screening result is reactive.
Exam overview
About the ASCP BOC Scientist in Blood Banking (BB) Examination Exam
Work through the reasoning behind pretransfusion testing: select an appropriate specimen, prepare red-cell suspensions, interpret reagent-cell reactions, and distinguish alloantibodies from autoantibodies. Transfusion-reaction scenarios call for connecting timing and clinical findings—such as fever, flank pain, hemoglobinuria, or isolated urticaria—to a likely reaction category. Component questions examine how products such as cryoprecipitate address fibrinogen replacement and how leukoreduction affects cellular components. Donor-focused items address collection practices, including the purpose of diversion pouches, and the handling of donations associated with reactive infection screening. These tasks reflect the practical need to combine serologic findings, product characteristics, and patient or donor information when supporting safe transfusion service decisions.
Sample Practice Questions
Review a selection from this exam's published US Practice Tests practice bank.
Which component is specifically intended to provide a high concentration of fibrinogen when a patient has clinically important hypofibrinogenemia and replacement is indicated?
Show answer
Correct answer: BCryoprecipitate is a concentrated source of fibrinogen, as well as factor XIII, von Willebrand factor, and factor VIII. It may be used for fibrinogen replacement when clinically indicated and consistent with local policy.
Which specimen is generally preferred for routine pretransfusion compatibility testing when collected and handled according to laboratory policy?
Show answer
Correct answer: AA correctly identified patient specimen in EDTA is commonly used for ABO/Rh typing, antibody screening, and compatibility testing. Specimen identification and collection requirements must follow institutional policy.
A patient develops fever, flank pain, and hemoglobinuria shortly after an incompatible red cell transfusion. Which event is most likely?
Show answer
Correct answer: AAbrupt symptoms such as fever, pain, and hemoglobinuria during or soon after transfusion are concerning for an acute hemolytic reaction, often due to ABO incompatibility. The transfusion should be stopped and the reaction investigated promptly.
A patient receiving a red-cell transfusion develops generalized urticaria and itching but remains hemodynamically stable, with no respiratory symptoms or fever. Which reaction category is most consistent with this presentation?
Show answer
Correct answer: BIsolated itching and urticaria without respiratory compromise or systemic instability are typical of a mild allergic transfusion reaction. Any transfusion reaction still requires prompt clinical assessment and management according to local policy.
Which pattern is most characteristic of a delayed hemolytic transfusion reaction caused by an anamnestic red-cell alloantibody?
Show answer
Correct answer: AA delayed hemolytic reaction can occur when a previously formed alloantibody has fallen below detection and rises again after antigen re-exposure. The patient may show an unexpected hemoglobin decline and newly detectable antibody days after transfusion; evaluation includes appropriate serologic and clinical investigation.
A patient with a history of multiple pregnancies has plasma that reacts with a subset of reagent red cells. Which finding would support that the antibody is an alloantibody rather than an autoantibody?
Show answer
Correct answer: AAn alloantibody is formed against an antigen the individual does not express. Demonstrating that the patient’s red cells lack the antigen corresponding to the plasma antibody supports an alloantibody interpretation; the full investigation also considers reaction patterns and clinical history.
What is the main purpose of leukoreduction of cellular blood components?
Show answer
Correct answer: ALeukoreduction lowers the number of donor leukocytes in cellular components. It can reduce febrile nonhemolytic reactions and the risk of HLA alloimmunization, but it does not eliminate all infectious risks or remove red cell antigens.
How to use this practice test
The free practice set draws up to 20 random questions from the published bank of 50. Submit a session to see results, then use missed items to identify specific gaps—for example, reaction recognition, antibody interpretation, or component selection. Revisit the underlying reasoning rather than memorizing a single answer.
Preparation tips
- For each transfusion-reaction scenario, compare onset, symptoms, and hemolysis findings to separate acute hemolytic, delayed hemolytic, and allergic patterns.
- Practice interpreting antibody-screen reactions against reagent-cell patterns, and explain what evidence favors an alloantibody over an autoantibody.
- Review the intended uses and key properties of components, including the role of cryoprecipitate in fibrinogen replacement and leukoreduction of cellular products.
- Trace routine pretransfusion testing from specimen selection through washed-cell suspension and compatibility assessment, following the laboratory procedures you use.
- Connect donor-collection and screening scenarios to appropriate handling, including the purpose of the diversion pouch and disposition considerations for a reactive infectious-disease screen.